Search research articles
Contact Us
Filters
Showing results (101-110 of 347) with videos related to
Page
of 35
Sort By:
Thoracic Cancer
|
January 15, 2016
Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer
Jianliang Yang, Yuankai Shi, Xiangru Zhang, et al.
Zhonghua Yi Xue Za Zhi
|
April 17, 2015
[Methodology comparison and influence factors analysis of epidermal growth factor receptor mutation detection]
Xiaoyan Qian, Shuai Wang, Yinchen Shen, et al.
BMC Cancer
|
October 29, 2022
Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer: a phase I dose-escalation and dose-expansion study
Wen Zhang, Xiaohong Han, Lin Yang, et al.
Thoracic Cancer
|
September 19, 2017
Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study
Shufei Yu, Yan Wang, Junling Li, et al.
Current Cancer Drug Targets
|
November 2, 2018
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
Caixia Liang, Ningning Zhang, Qiaoyun Tan, et al.
Analytical and Bioanalytical Chemistry
|
February 6, 2015
Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers
Li Yang, Xinge Cui, Ningning Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers
|
July 11, 2013
Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer
Jianfei Wang, Hongying Yang, Yinchen Shen, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 13, 2018
Clinicopathologic characteristics and outcome of patients with different EGFR mutations
Shengyu Zhou, Xingsheng Hu, Yan Wang, et al.
Journal of Translational Medicine
|
June 1, 2022
Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC
Shasha Wang, Ning Lou, Rongrong Luo, et al.
Biomarker Research
|
June 5, 2024
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma
Liyuan Dai, Guangyu Fan, Tongji Xie, et al.
Page
of 35
Search research articles
Search
Showing results (101-110 of 347) with videos related to
Sort By:
Page
of 35
Thoracic Cancer
|
January 15, 2016
Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer
Jianliang Yang, Yuankai Shi, Xiangru Zhang, et al.
Zhonghua Yi Xue Za Zhi
|
April 17, 2015
[Methodology comparison and influence factors analysis of epidermal growth factor receptor mutation detection]
Xiaoyan Qian, Shuai Wang, Yinchen Shen, et al.
BMC Cancer
|
October 29, 2022
Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer: a phase I dose-escalation and dose-expansion study
Wen Zhang, Xiaohong Han, Lin Yang, et al.
Thoracic Cancer
|
September 19, 2017
Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study
Shufei Yu, Yan Wang, Junling Li, et al.
Current Cancer Drug Targets
|
November 2, 2018
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
Caixia Liang, Ningning Zhang, Qiaoyun Tan, et al.
Analytical and Bioanalytical Chemistry
|
February 6, 2015
Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers
Li Yang, Xinge Cui, Ningning Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers
|
July 11, 2013
Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer
Jianfei Wang, Hongying Yang, Yinchen Shen, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 13, 2018
Clinicopathologic characteristics and outcome of patients with different EGFR mutations
Shengyu Zhou, Xingsheng Hu, Yan Wang, et al.
Journal of Translational Medicine
|
June 1, 2022
Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC
Shasha Wang, Ning Lou, Rongrong Luo, et al.
Biomarker Research
|
June 5, 2024
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma
Liyuan Dai, Guangyu Fan, Tongji Xie, et al.
Page
of 35